|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proximagen is dedicated to discovering and developing innovative therapies to
improve the lives of patients with neurodegenerative diseases.
Our six goal strategy seeks to achieve this goal
while bringing significant returns to our shareholders.
-
Offer a rewarding corporate culture to motivate and retain our employees
- In-license selective lead candidates for late stage preclinical and early stage clinical development
- Maintain a consistent compound pipeline
- Retention of strong downstream participation in all collaborative programs
- Deliver a new therapeutic candidate within 3 years from our own discovery programme
- Maintain a controlled cash burn
|
|
|
|
|
|
|
